Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Cancer Research|November 6, 2009
Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cellsHamed Shojaei, Hans-Heinrich Oberg, Matthias Juricke, et al.
Oncotarget|November 5, 2017
A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display librariesKatja Klausz, Michael Cieker, Christian Kellner, et al.
Journal of Cell Science|February 8, 2008
A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasionAndreas Till, Philip Rosenstiel, Karen Bräutigam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2015
Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B CellsSusann Hüttl, Kathrin Kläsener, Michaela Schweizer, et al.
Frontiers in Immunology|September 27, 2019
TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer CellsDoaa Tawfik, Christopher Groth, Jan-Paul Gundlach, et al.
Frontiers in Immunology|August 4, 2025
Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancerHans-Heinrich Oberg, Malte Deseke, Steffen Krohn, et al.
Frontiers in Immunology|September 29, 2025
Correction: Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancerHans-Heinrich Oberg, Malte Deseke, Steffen Krohn, et al.
International Journal of Cancer|March 26, 2013
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17Guranda Chitadze, Marcus Lettau, Jaydeep Bhat, et al.
Journal of Leukocyte Biology|December 14, 2019
Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumorsHans-Heinrich Oberg, Lisa Janitschke, Vjola Sulaj, et al.
Oncotarget|March 23, 2019
POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinomaSascha Rahn, Sandra Krüger, Ruben Mennrich, et al.
Pageof 7